City
Epaper

Kerala HC asks Centre to explain why 84 days wait for Covishield

By IANS | Updated: August 24, 2021 16:15 IST

Kochi, Aug 24 The Kerala High Court on Tuesday asked the Centre to explain why there is a ...

Open in App

Kochi, Aug 24 The Kerala High Court on Tuesday asked the Centre to explain why there is a gap of 84 days for second dose of Covishield vaccine.

The court also asked if it was possible to reduce the time gap if vaccines are sourced by parties themselves.

The court made this remark when hearing a petition filed by the Kitex group of companies which pointed out that initially the time frame for taking the second dose of Covishield was 45 days.

The court asked whether the time gap was extended because it had better efficacy or was it because of the problems in sourcing vaccines in time.

The Centre has been asked by the court to give its affidavit on these issues and posted the case for Thursday.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: KitexKerala High Court
Open in App

Related Stories

EntertainmentMalayalam Actor Siddique Goes Missing After Court Denies Bail In Rape Case; Police Launch Search

EntertainmentHema Committee Report: Siddique To Face Jail Term in Sexual Harassment Case? Kerala High Court Rejects Actor's Bail Plea

EntertainmentHema Committee Report: Kerala HC Dismisses Actor Siddique’s Anticipatory Bail Plea in Rape Case

NationalHema Committee Report: Kerala High Court Raps Kerala Government, Says ‘You Have Done Nothing in 4 Years’

NationalHema Committee Report: Kerala High Court To Form Five-Judge Bench To Hear Petitions

Health Realted Stories

HealthDabur India Q4 net profit falls over 8 pc YoY

HealthIndia's wireless subscriber base hits 1.16 billion in March, grows 0.28% monthly: TRAI

HealthWorld's wealthiest 10pc contributing most to global warming than poorest 50pc: Study

HealthTamil Nadu to launch organised cancer screening programme in 12 districts

HealthStudy shows diabetes drug may help treat prostate cancer